Market Closed -
Nyse
04:00:02 2024-06-06 pm EDT
|
5-day change
|
1st Jan Change
|
98.26
USD
|
-0.20%
|
|
-1.52%
|
+17.68%
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,619
|
2,034
|
2,843
|
3,597
|
3,875
|
5,441
|
-
|
-
|
Enterprise Value (EV)
1 |
3,514
|
2,998
|
3,837
|
4,834
|
4,913
|
6,418
|
6,347
|
6,317
|
P/E ratio
|
17.2
x
|
-8.56
x
|
11.5
x
|
-
|
-
|
-
|
-
|
-
|
Yield
|
3%
|
3.89%
|
2.79%
|
2.32%
|
2.22%
|
1.7%
|
1.86%
|
2.02%
|
Capitalization / Revenue
|
0.78
x
|
0.78
x
|
0.83
x
|
0.83
x
|
0.99
x
|
1.36
x
|
1.29
x
|
1.24
x
|
EV / Revenue
|
1.05
x
|
1.15
x
|
1.13
x
|
1.12
x
|
1.25
x
|
1.61
x
|
1.5
x
|
1.44
x
|
EV / EBITDA
|
6.49
x
|
7.51
x
|
5.88
x
|
6.64
x
|
7.07
x
|
8.18
x
|
7.45
x
|
7
x
|
EV / FCF
|
25.6
x
|
16.9
x
|
61.9
x
|
-43.5
x
|
14
x
|
22.1
x
|
31.7
x
|
28.3
x
|
FCF Yield
|
3.9%
|
5.9%
|
1.62%
|
-2.3%
|
7.14%
|
4.52%
|
3.16%
|
3.53%
|
Price to Book
|
2.59
x
|
2.94
x
|
3
x
|
4.02
x
|
-
|
3.79
x
|
3.3
x
|
2.94
x
|
Nbr of stocks (in thousands)
|
57,783
|
56,462
|
56,724
|
56,299
|
55,937
|
55,258
|
-
|
-
|
Reference price
2 |
45.32
|
36.03
|
50.12
|
63.89
|
69.27
|
98.46
|
98.46
|
98.46
|
Announcement Date
|
11/4/19
|
11/23/20
|
11/8/21
|
11/7/22
|
11/6/23
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,337
|
2,614
|
3,409
|
4,321
|
3,931
|
3,995
|
4,219
|
4,381
|
EBITDA
1 |
541
|
399
|
652
|
728
|
695
|
784.5
|
852.2
|
902.9
|
EBIT
1 |
394
|
242
|
492
|
583
|
553
|
631.1
|
695.5
|
740.9
|
Operating Margin
|
11.81%
|
9.26%
|
14.43%
|
13.49%
|
14.07%
|
15.8%
|
16.49%
|
16.91%
|
Earnings before Tax (EBT)
1 |
255
|
-33
|
406
|
335
|
451
|
551.8
|
628
|
693.1
|
Net income
|
157
|
-238
|
250
|
209
|
445
|
-
|
-
|
-
|
Net margin
|
4.7%
|
-9.1%
|
7.33%
|
4.84%
|
11.32%
|
-
|
-
|
-
|
EPS
|
2.630
|
-4.210
|
4.340
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
137
|
177
|
62
|
-111
|
351
|
290
|
200.5
|
223
|
FCF margin
|
4.11%
|
6.77%
|
1.82%
|
-2.57%
|
8.93%
|
7.26%
|
4.75%
|
5.09%
|
FCF Conversion (EBITDA)
|
25.32%
|
44.36%
|
9.51%
|
-
|
50.5%
|
36.97%
|
23.53%
|
24.7%
|
FCF Conversion (Net income)
|
87.26%
|
-
|
24.8%
|
-
|
78.88%
|
-
|
-
|
-
|
Dividend per Share
2 |
1.360
|
1.400
|
1.400
|
1.480
|
1.540
|
1.677
|
1.836
|
1.987
|
Announcement Date
|
11/4/19
|
11/23/20
|
11/8/21
|
11/7/22
|
11/6/23
|
-
|
-
|
-
|
Fiscal Period: September |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
---|
Net sales
1 |
968
|
1,092
|
1,149
|
1,112
|
965
|
1,033
|
968
|
965
|
958
|
1,019
|
1,004
|
1,007
|
1,041
|
1,092
|
1,048
|
EBITDA
1 |
162
|
191
|
197
|
178
|
142
|
170
|
189
|
194
|
181
|
199
|
201.2
|
203.3
|
212.7
|
223
|
213
|
EBIT
1 |
123
|
155
|
162
|
143
|
108
|
134
|
153
|
158
|
140
|
162
|
164.4
|
163.2
|
173.3
|
182.7
|
172
|
Operating Margin
|
12.71%
|
14.19%
|
14.1%
|
12.86%
|
11.19%
|
12.97%
|
15.81%
|
16.37%
|
14.61%
|
15.9%
|
16.37%
|
16.21%
|
16.65%
|
16.73%
|
16.41%
|
Earnings before Tax (EBT)
1 |
-93
|
147
|
152
|
129
|
84
|
110
|
130
|
127
|
-
|
142
|
143.1
|
143.7
|
-
|
-
|
-
|
Net income
|
-89
|
107
|
97
|
94
|
54
|
75
|
82
|
234
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-9.19%
|
9.8%
|
8.44%
|
8.45%
|
5.6%
|
7.26%
|
8.47%
|
24.25%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-1.570
|
1.840
|
-
|
-
|
0.9300
|
1.290
|
1.430
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.3700
|
0.3700
|
0.3700
|
0.3700
|
0.3700
|
-
|
0.4000
|
-
|
-
|
-
|
0.4325
|
0.4758
|
0.4758
|
0.4758
|
0.4758
|
Announcement Date
|
1/31/22
|
5/2/22
|
8/8/22
|
11/7/22
|
2/9/23
|
5/8/23
|
8/7/23
|
11/6/23
|
2/5/24
|
5/6/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
895
|
964
|
994
|
1,237
|
1,038
|
977
|
906
|
877
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.654
x
|
2.416
x
|
1.525
x
|
1.699
x
|
1.494
x
|
1.246
x
|
1.063
x
|
0.9709
x
|
Free Cash Flow
1 |
137
|
177
|
62
|
-111
|
351
|
290
|
201
|
223
|
ROE (net income / shareholders' equity)
|
21.4%
|
13.9%
|
34.8%
|
39%
|
28.1%
|
28.2%
|
27.6%
|
26.7%
|
ROA (Net income/ Total Assets)
|
7.36%
|
4.07%
|
9.37%
|
10.5%
|
8.53%
|
10.4%
|
11.1%
|
11.6%
|
Assets
|
2,133
|
-5,848
|
2,668
|
1,983
|
5,218
|
-
|
-
|
-
|
Book Value Per Share
2 |
17.50
|
12.20
|
16.70
|
15.90
|
-
|
26.00
|
29.80
|
33.50
|
Cash Flow per Share
2 |
6.140
|
6.660
|
4.520
|
1.760
|
10.50
|
9.540
|
10.40
|
11.10
|
Capex
1 |
224
|
200
|
195
|
211
|
244
|
241
|
285
|
294
|
Capex / Sales
|
6.71%
|
7.65%
|
5.72%
|
4.88%
|
6.21%
|
6.03%
|
6.76%
|
6.71%
|
Announcement Date
|
11/4/19
|
11/23/20
|
11/8/21
|
11/7/22
|
11/6/23
|
-
|
-
|
-
|
Last Close Price
98.46
USD Average target price
107.6
USD Spread / Average Target +9.28% Consensus |
1st Jan change
|
Capi.
|
---|
| +17.68% | 5.44B | | +21.26% | 68.31B | | -0.07% | 48.94B | | +24.11% | 44.65B | | +29.59% | 27.81B | | +7.64% | 19.14B | | +10.10% | 16.76B | | -5.26% | 16.05B | | -23.26% | 15.55B | | -18.20% | 13.94B |
Other Specialty Chemicals
|